Information Provided By:
Fly News Breaks for May 1, 2015
PCRX
May 1, 2015 | 07:23 EDT
Jefferies lowered its price target for Pacira Pharmaceuticals to $81 after the reported weaker than expected Exparel revenue and withdrew its prior guidance. The firm sees uncertainty but thinks the company's growth profile should "remain robust." It keeps a Buy rating on the name.
News For PCRX From the Last 2 Days
There are no results for your query PCRX